# Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

> **NCT06743646** · PHASE3 · RECRUITING · sponsor: **Chigenovo Co., Ltd** · enrollment: 62 (estimated)

## Conditions studied

- Bietti Crystalline Corneoretinal Dystrophy
- Bietti Crystalline Dystrophy

## Interventions

- **DRUG:** ZVS101e

## Key facts

- **NCT ID:** NCT06743646
- **Lead sponsor:** Chigenovo Co., Ltd
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-27
- **Primary completion:** 2026-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06743646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06743646, "Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06743646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*